Trademark: 97549234
Word
NVS NOVELSTAR PHARMACEUTICALS INC.
Status Date
Monday, June 10, 2024
Filing Date
Monday, August 15, 2022
Published for Opposition
Tuesday, October 24, 2023
5 Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations for use in treatment of human diseases and disorders, namely, skin disorders, eye disorders, cardiovascular diseases, diseases of the digestive systems, diseases of the blood system, neurological diseases, musculoskeletal diseases, infectious diseases, urological diseases, immunological diseases, allergies, wounds, hypertension, cancer, pain, diabetes
The mark consists of a circle with enclosed stylized text of "NVS", followed by text which reads "NOVELSTAR", under which is set forth a text "PHARMACEUTICALS INC."
Color is not claimed as a feature of the mark.
"PHARMACEUTICALS INC."
Aug 18, 2022
New Application Entered
Sep 3, 2022
New Application Office Supplied Data Entered
Sep 6, 2022
Notice Of Design Search Code E-Mailed
Jun 1, 2023
Assigned To Examiner
Jun 14, 2023
Non-Final Action Written
Jun 14, 2023
Non-Final Action E-Mailed
Jun 14, 2023
Notification Of Non-Final Action E-Mailed
Sep 14, 2023
Teas Response To Office Action Received
Sep 14, 2023
Correspondence Received In Law Office
Sep 14, 2023
Teas/Email Correspondence Entered
Sep 19, 2023
Examiners Amendment -Written
Sep 19, 2023
Examiners Amendment E-Mailed
Sep 19, 2023
Notification Of Examiners Amendment E-Mailed
Sep 19, 2023
Examiner's Amendment Entered
Sep 19, 2023
Approved For Pub - Principal Register
Oct 4, 2023
Notification Of Notice Of Publication E-Mailed
Oct 24, 2023
Published For Opposition
Oct 24, 2023
Official Gazette Publication Confirmation E-Mailed
Dec 19, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 10, 2024
Teas Petition To Amend Basis Received
Jun 10, 2024
Sou Teas Extension Received
Jun 10, 2024
Sou Extension 1 Granted
Jun 10, 2024
Sou Extension 1 Filed
Jun 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
